Kinnate Biopharma Inc (KNTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 121,176 | 118,521 | 90,111 | 36,001 | 12,012 |
| Operating Income | -121,176 | -118,521 | -90,111 | -36,001 | -12,012 |
| Other Income | 8,527 | 2,250 | 348 | 240 | 43 |
| Pre-tax Income | -112,649 | -116,271 | -89,763 | -35,761 | -11,969 |
| Net Income Continuous | -112,649 | -116,271 | -89,763 | -35,761 | -11,969 |
| Net Income | $-112,649 | $-116,271 | $-89,763 | $-35,761 | $-11,969 |
| EPS Basic Total Ops | -2.42 | -2.64 | -2.06 | -5.28 | -2.72 |
| EPS Basic Continuous Ops | -2.42 | -2.64 | -2.06 | -5.28 | -3.27 |
| EPS Diluted Total Ops | -2.42 | -2.64 | -2.06 | -5.28 | -2.72 |
| EPS Diluted Continuous Ops | -2.42 | -2.64 | -2.06 | -5.28 | -3.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.64 | -2.06 | -5.28 | N/A |
| EBITDA(a) | $-124,784 | $-117,235 | $-88,111 | $-35,913 | $-12,012 |